Benzinga | Nov 2, 2021 10:54AM EDT

Oppenheimer Maintains Outperform on EverQuote, Lowers Price Target to $20

Oppenheimer analyst Jed Kelly maintains EverQuote (NASDAQ:EVER) with a Outperform and lowers the price target from $45 to $20.